Propofol: A review of its non-anaesthetic effects

European Journal of Pharmacology

Volumn 605, Issue 1-3, 2009, Pages 1-8

  Vasileiou, Ioanna ^a   Xanthos, Theodoros ^a   Koudouna, Eleni ^a   Perrea, Despoina ^a   Klonaris, Chris ^b   Katsargyris, Athanasios ^b   Papadimitriou, Lila ^a  

^a Department of Experimental Surgery and Surgical Research ^*  (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Antiemetic; Antioxidative property; Anxiolytic property; Nitric oxide; Propofol

Indexed keywords

ADENOSINE DIPHOSPHATE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; POTASSIUM CHANNEL; PROPOFOL; THROMBIN;

AGITATION; ALLODYNIA; AMNESIA; ANALGESIC ACTIVITY; ANTIEMETIC ACTIVITY; ANTIOXIDANT ACTIVITY; CALCIUM CELL LEVEL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNOMODULATION; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION; TRANQUILIZING ACTIVITY;

ANESTHETICS, INTRAVENOUS; ANIMALS; ANTIEMETICS; HUMANS; HYPNOTICS AND SEDATIVES; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; OXIDATIVE STRESS; PROPOFOL;

EID: 60349115001     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.01.007     Document Type: Review

References (123)

1. Acquaviva R., Campisi A., Murabito P., Raciti G., Avola R., Mangiameli S., Musumeci I., Barcellona M.L., Vanella A., and Li Volti G. Propofol attenuates peroxynitrite-mediated DNA damage and apoptosis in cultured astrocytes: an alternative protective mechanism. Anesthesiology 101 (2004) 1363-1371
2. Adembri C., Venturi L., Tani A., Chiarugi A., Gramigni E., Cozzi A., Pancani T., De Gaudio R.A., and Pellegrini-Giampietro D.E. Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology 104 (2006) 80-89
3. Alkire M.T., Vazdarjanova A., Dickinson-Anson H., White N.S., and Cahill L. Lesions of the basolateral amygdala complex block propofol-induced amnesia for inhibitory avoidance learning in rats. Anesthesiology 95 (2001) 708-715
4. Anker-Moller E., Spangsberg N., Arendt-Nielsen L., Schultz P., Kristensen M.S., and Bjerring P. Subhypnotic doses of thiopentone and propofol cause analgesia to experimentally induced acute pain. Br. J. Anaesth. 66 (1991) 185-188
5. Ansley D.M., Lee J., Godin D.V., Garnett M.E., and Qayumi A.K. Propofol enhances red cell antioxidant capacity in swine and humans. Can. J. Anaesth. 45 (1998) 233-239
6. Aoki H., Mizobe T., Nozuchi S., and Hiramatsu N. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation. Anesthesiology 88 (1998) 362-370
7. Appadu B.L., Strange P.G., and Lambert D.G. Does propofol interact with D2 dopamine receptors?. Anaesth. Analg. 79 (1994) 1191-1192
8. Arcadi F.A., Rapisarda A., De Luca R., Trimarchi G.R., and Costa G. Effect of 2,6-diisopropylphenol on the delayed hippocampal cell loss following transient forebrain ischemia in the gerbil. Life Sci. 58 (1996) 961-970
9. Bagdy G., Graf M., Anheuer Z.E., Modos E.A., and Kantor S. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int. J. Neuropsychopharmacol. 4 (2001) 399-408
10. Barann M., Gothert M., Fink K., and Bonisch H. Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 347 (1993) 125-132
11. Barann M., Dilger J.P., Bonisch H., Gothert M., Dybek A., and Urban B.W. Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements. Neuropharmacology 39 (2000) 1064-1074
12. Barann M., Linden I., Witten S., and Urban B.W. Molecular actions of propofol on human 5-HT3A receptors: enhancement as well as inhibition by closely related phenol derivatives. Anesth. Analg. 106 (2008) 846-857 table of contents
13. Bevensee M.O., Weed R.A., and Boron W.F. Intracellular pH regulation in cultured astrocytes from rat hippocampus. I. Role Of HCO3. J. Gen. Physiol. 110 (1997) 453-465
14. Borgeat A. Subhypnotic doses of propofol do not possess antidopaminergic properties. Anaesth. Analg. 84 (1997) 196-198
15. Borgeat A., and Stirnemann H.R. [Antiemetic effect of propofol]. Anaesthesist 47 (1998) 918-924
16. Borgeat A., Dessibourg C., Popovic V., Meier D., Blanchard M., and Schwander D. Propofol and spontaneous movements: an EEG study. Anesthesiology 74 (1991) 24-27
17. Borgeat A., Wilder-Smith O.H., and Suter P.M. The nonhypnotic therapeutic applications of propofol. Anesthesiology 80 (1994) 642-656
18. Briggs L.P., Dundee J.W., Bahar M., and Clarke R.S. Comparison of the effect of diisopropyl phenol (ICI 35, 868) and thiopentone on response to somatic pain. Br. J. Anaesth. 54 (1982) 307-311
19. Bulger E.M., and Maier R.V. Lipid mediators in the pathophysiology of critical illness. Crit. Care Med. 28 (2000) N27-36
20. Cavazzuti M., Porro C.A., Barbieri A., and Galetti A. Brain and spinal cord metabolic activity during propofol anaesthesia. Br. J. Anaesth. 66 (1991) 490-495
21. Chang H.R., Cordon-Cardo C., Houghton A.N., Cheung N.K., and Brennan M.F. Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas. Cancer 70 (1992) 633-638
22. Cockshott I.D. Propofol ('Diprivan') pharmacokinetics and metabolism-an overview. Postgrad. Med. J. 61 Suppl 3 (1985) 45-50
23. Concas A., Santoro G., Serra M., Sanna E., and Biggio G. Neurochemical action of the general anaesthetic propofol on the chloride ion channel coupled with GABAA receptors. Brain Res. 542 (1991) 225-232
24. Corcoran T.B., Engel A., Sakamoto H., O'Callaghan-Enright S., O'Donnell A., Heffron J.A., and Shorten G. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J. Cardiothorac. Vasc. Anesth. 18 (2004) 592-604
25. Costall B., and Naylor R.J. 5-HT3 receptors. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 27-37
26. Cromheecke S., Pepermans V., Hendrickx E., Lorsomradee S., Ten Broecke P.W., Stockman B.A., Rodrigus I.E., and De Hert S.G. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anaesth. Analg. 103 (2006) 289-296 table of contents
27. D'Esposito M., Postle B.R., and Rypma B. Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Experimental brain research. Exp. Hirnforschung 133 (2000) 3-11
28. Dandoy M., Poisson F., Lampl E., Reynaud S., Rondet S., Proust M.N., Mallet A., and Maurin J.P. [Anaesthesia using propofol during surgery of strabismus in children. A comparison of two different protocols of induction and maintenance]. Cah. Anesthésiol. 38 (1990) 241-245
29. Daskalopoulos R., Korcok J., Farhangkhgoee P., Karmazyn M., Gelb A.W., and Wilson J.X. Propofol protection of sodium-hydrogen exchange activity sustains glutamate uptake during oxidative stress. Anesth. Analg. 93 (2001) 1199-1204
30. De La Cruz J.P., Paez M.V., Carmona J.A., and De La Cuesta F.S. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. Br. J. Pharmacol. 128 (1999) 1538-1544
31. Deeprose C., Andrade J., Varma S., and Edwards N. Unconscious learning during surgery with propofol anaesthesia. Br. J. Anaesth. 92 (2004) 171-177
32. Delogu G., Antonucci A., Signore M., Marandola M., Tellan G., and Ippoliti F. Plasma levels of IL-10 and nitric oxide under two different anaesthesia regimens. Eur. J. Anaesthesiol. 22 (2005) 462-466
33. Dong X.P., and Xu T.L. The actions of propofol on gamma-aminobutyric acid-A and glycine receptors in acutely dissociated spinal dorsal horn neurons of the rat. Anaesth. Analg. 95 (2002) 907-914 table of contents
34. + channels that are inhibited by ATP in an insulin-secreting cell line. FEBS Lett. 208 (1986) 59-62
35. Engelhard K., Werner C., Eberspacher E., Pape M., Stegemann U., Kellermann K., Hollweck R., Hutzler P., and Kochs E. Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation. Anesthesiology 101 (2004) 912-917
36. Ergun R., Akdemir G., Sen S., Tasci A., and Ergungor F. Neuroprotective effects of propofol following global cerebral ischemia in rats. Neurosurg. Rev. 25 (2002) 95-98
37. Feiner J.R., Bickler P.E., Estrada S., Donohoe P.H., Fahlman C.S., and Schuyler J.A. Mild hypothermia, but not propofol, is neuroprotective in organotypic hippocampal cultures. Anaesth. Analg. 100 (2005) 215-225
38. Fourcade O., Simon M.F., Litt L., Samii K., and Chap H. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. Anesth. Analg. 99 (2004) 393-398 table of contents
39. Gelb A.W., Bayona N.A., Wilson J.X., and Cechetto D.F. Propofol anaesthesia compared to awake reduces infarct size in rats. Anesthesiology 96 (2002) 1183-1190
40. Glen J.B. Animal studies of the anaesthetic activity of ICI 35 868. Br. J. Anaesth. 52 (1980) 731-742
41. Glen J.B., and Hunter S.C. Pharmacology of an emulsion formulation of ICI 35 868. Br. J. Anaesth. 56 (1984) 617-626
42. Gonzalez-Correa J.A., Cruz-Andreotti E., Arrebola M.M., Lopez-Villodres J.A., Jodar M., and De La Cruz J.P. Effects of propofol on the leukocyte nitric oxide pathway: in vitro and ex vivo studies in surgical patients. Naunyn-Schmiedeberg's Arch. Pharmacol. 376 (2008) 331-339
43. Grouzmann E., Borgeat A., Fathi M., Gaillard R.C., and Ravussin P. Plasma and cerebrospinal fluid concentration of neuropeptide Y, serotonin, and catecholamines in patients under propofol or isoflurane anaesthesia. Can. J. Physiol. Pharm. 78 (2000) 100-107
44. Guzik T.J., Korbut R., and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54 (2003) 469-487
45. Hales T.G., and Lambert J.J. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br. J. Pharmacol. 104 (1991) 619-628
46. Handley S.L. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol. Ther. 66 (1995) 103-148
47. Hans P., Deby-Dupont G., Deby C., Pieron F., Verbesselt R., Franssen C., and Lamy M. Increase in antioxidant capacity of plasma during propofol anaesthesia. J. Neurosurg. Anesthesiol. 9 (1997) 234-236
48. Hara M., Kai Y., and Ikemoto Y. Propofol activates GABAA receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 79 (1993) 781-788
49. Helmy S.A., and Al-Attiyah R.J. The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia 56 (2001) 4-8
50. Hirakata H., Nakamura K., Yokubol B., Toda H., Hatano Y., Urabe N., and Mori K. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. Anesthesiology 91 (1999) 1361-1369
51. Hokey D.A., Larregina A.T., Erdos G., Watkins S.C., and Falo Jr. L.D. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity. Cancer Res. 65 (2005) 10059-10067
52. Iijima T., Mishima T., Akagawa K., and Iwao Y. Neuroprotective effect of propofol on necrosis and apoptosis following oxygen-glucose deprivation-relationship between mitochondrial membrane potential and mode of death. Brain Res. 1099 (2006) 25-32
53. Imaizumi T.A., Stafforini D.M., Yamada Y., McIntyre T.M., Prescott S.M., and Zimmerman G.A. Platelet-activating factor: a mediator for clinicians. J. Intern. Med. 238 (1995) 5-20
54. Ishii H., Arai T., Segawa H., Morikawa S., Inubushi T., and Fukuda K. Effects of propofol on lactate accumulation and oedema formation in focal cerebral ischaemia in hyperglycaemic rats. Br. J. Anaesth. 88 (2002) 412-417
55. Ito H., Watanabe Y., Isshiki A., and Uchino H. Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors. Acta Anaesthesiol. Scand. 43 (1999) 153-162
56. Jewett B.A., Gibbs L.M., Tarasiuk A., and Kendig J.J. Propofol and barbiturate depression of spinal nociceptive neurotransmission. Anesthesiology 77 (1992) 1148-1154
57. Jost U., Dorsing C., Jahr C., and Hirschauer M. [Propofol and postoperative nausea and/or vomiting]. Anaesthesist 46 (1997) 776-782
58. Karahalil B., Yagar S., Bahadir G., Durak P., and Sardas S. Diazepam and propofol used as anaesthetics during open-heart surgery do not cause chromosomal aberrations in peripheral blood lymphocytes. Mutat. Res. 581 (2005) 181-186
59. Kawano T., Oshita S., Takahashi A., Tsutsumi Y., Tomiyama Y., Kitahata H., Kuroda Y., and Nakaya Y. Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 100 (2004) 338-346
60. Kawano T., Oshita S., Takahashi A., Tsutsumi Y., Tanaka K., Tomiyama Y., Kitahata H., and Nakaya Y. Molecular mechanisms underlying ketamine-mediated inhibition of sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 102 (2005) 93-101
61. Knowles R.G., and Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298 Pt 2 (1994) 249-258
62. Kochs E., Hoffman W.E., Werner C., Thomas C., Albrecht R.F., and Schulte am Esch J. The effects of propofol on brain electrical activity, neurologic outcome, and neuronal damage following incomplete ischemia in rats. Anesthesiology 76 (1992) 245-252
63. Kudoh A., Katagai H., and Takazawa T. Plasma inflammatory cytokine response to surgical trauma in chronic depressed patients. Cytokine 13 (2001) 104-108
64. Kurt M., Bilge S.S., Kukula O., Celik S., and Kesim Y. Anxiolytic-like profile of propofol, a general anaesthetic, in the plus-maze test in mice. Pol. J. Pharmacol. 55 (2003) 973-977
65. Kushida A., Inada T., and Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol. Immunotoxicol. 29 (2007) 477-486
66. Lambert D.G., and Appadu B.L. Muscarinic receptor subtypes: do they have a place in clinical anaesthesia?. Br. J. Anaesth. 74 (1995) 497-499
67. Lascola C., and Kraig R.P. Astroglial acid-base dynamics in hyperglycemic and normoglycemic global ischemia. Neurosci. Biobehav. Rev. 21 (1997) 143-150
68. Lisman J.E., and Idiart M.A. Storage of 7 +/- 2 short-term memories in oscillatory subcycles. Science (New York, N.Y) 267 (1995) 1512-1515
69. Liu M.C., Tsai P.S., Yang C.H., Liu C.H., Chen C.C., and Huang C.J. Propofol significantly attenuates iNOS, CAT-2, and CAT-2B transcription in lipopolysaccharide-stimulated murine macrophages. Acta Anaesthesiol. Taiwan 44 (2006) 73-81
70. Manataki A.D., Tselepis A.D., Glantzounis G.K., Arnaoutoglou H.M., Tsimoyiannis E.C., and Stavropoulos N.E. Lipid peroxidation and the use of emulsified propofol in laparoscopic surgery. Surg. Endosc. 15 (2001) 950-953
71. Marinovic J., Bosnjak Z.J., and Stadnicka A. Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. Anesthesiology 105 (2006) 98-104
72. Mathy-Hartert M., Mouithys-Mickalad A., Kohnen S., Deby-Dupont G., Lamy M., and Hans P. Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia 55 (2000) 1066-1071
73. Matsuo M., Ayuse T., Oi K., and Kataoka Y. Propofol produces anticonflict action by inhibiting 5-HT release in rat dorsal hippocampus. Neuroreport 8 (1997) 3087-3090
74. McCollum J.S., Milligan K.R., and Dundee J.W. The antiemetic action of propofol. Anaesthesia 43 (1988) 239-240
75. Mendez D., De la Cruz J.P., Arrebola M.M., Guerrero A., Gonzalez-Correa J.A., Garcia-Temboury E., and Sanchez de la Cuesta F. The effect of propofol on the interaction of platelets with leukocytes and erythrocytes in surgical patients. Anesth. Analg. 96 (2003) 713-719 table of contents
76. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 57 (1999) 1-164
77. Minami M., Endo T., Hirafuji M., Hamaue N., Liu Y., Hiroshige T., Nemoto M., Saito H., and Yoshioka M. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol. Ther. 99 (2003) 149-165
78. Miyawaki I., Nakamura K., Yokubol B., Kitamura R., and Mori K. Suppression of cyclic guanosine monophosphate formation in rat cerebellar slices by propofol, ketamine and midazolam. Can. J. Anaesth. 44 (1997) 1301-1307
79. Nadeson R., and Goodchild C.S. Antinociceptive properties of propofol: involvement of spinal cord gamma-aminobutyric acid(A) receptors. J. Pharmacol. Exp. Ther. 282 (1997) 1181-1186
80. Nakamori M., Iwahashi M., Nakamura M., Ueda K., Zhang X., and Yamaue H. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. Clin. Cancer Res. 9 (2003) 2357-2365
81. Nietgen G.W., and Durieux M.E. Intercellular signaling by lysophosphatidate. Cell Adhes. Commun. 5 (1998) 221-235
82. Nishimura T., Iwakabe K., Sekimoto M., Ohmi Y., Yahata T., Nakui M., Sato T., Habu S., Tashiro H., Sato M., and Ohta A. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J. Exp. Med. 190 (1999) 617-627
83. Nishiyama T., Matsukawa T., and Hanaoka K. Intrathecal propofol has analgesic effects on inflammation-induced pain in rats. Can. J. Anaesth. = Journal canadien d'anesthesie 51 (2004) 899-904
84. + channels in cardiac muscle. Nature 305 (1983) 147-148
85. Nordstrom O., and Sandin R. Recall during intermittent propofol anaesthesia. Br. J. Anaesth. 76 (1996) 699-701
86. Pain L., Oberling P., Launoy A., and Di Scala G. Effect of nonsedative doses of propofol on an innate anxiogenic situation in rats. Anesthesiology 90 (1999) 191-196
87. Peters C.E., Korcok J., Gelb A.W., and Wilson J.X. Anaesthetic concentrations of propofol protect against oxidative stress in primary astrocyte cultures: comparison with hypothermia. Anesthesiology 94 (2001) 313-321
88. Pittman J.E., Sheng H., Pearlstein R., Brinkhous A., Dexter F., and Warner D.S. Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarct size after temporary focal ischemia in the rat. Anesthesiology 87 (1997) 1139-1144
89. Ramani R., Qiu M., and Constable R.T. Sevoflurane 0.25 MAC preferentially affects higher order association areas: a functional magnetic resonance imaging study in volunteers. Anaesth. Analg. 105 (2007) 648-655
90. Rossi M.A., Chan C.K., Christensen J.D., DeGuzman E.J., and Durieux M.E. Interactions between propofol and lipid mediator receptors: inhibition of lysophosphatidate signaling. Anesth. Analg. 83 (1996) 1090-1096
91. Salem M.L. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines. Int. Immunopharmacol. 5 (2005) 947-960
92. Salem M.L., Kishihara K., Abe K., Matsuzaki G., and Nomoto K. N-3 polyunsaturated fatty acids accentuate B16 melanoma growth and metastasis through suppression of tumoricidal function of T cells and macrophages. Anticancer Res. 20 (2000) 3195-3203
93. Salo M., Pirttikangas C.O., and Pulkki K. Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia 52 (1997) 341-344
94. Sanchez-Conde P., Rodriguez-Lopez J.M., Nicolas J.L., Lozano F.S., Garcia-Criado F.J., Cascajo C., Gonzalez-Sarmiento R., and Muriel C. The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesth. Analg. 106 (2008) 371-378 table of contents
95. Scapagnini G., Foresti R., Calabrese V., Giuffrida Stella A.M., Green C.J., and Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol. Pharmacol. 61 (2002) 554-561
96. Shtoyerman E., Arieli A., Slovin H., Vanzetta I., and Grinvald A. Long-term optical imaging and spectroscopy reveal mechanisms underlying the intrinsic signal and stability of cortical maps in V1 of behaving monkeys. J. Neurosci. 20 (2000) 8111-8121
97. Sitar S.M., Hanifi-Moghaddam P., Gelb A., Cechetto D.F., Siushansian R., and Wilson J.X. Propofol prevents peroxide-induced inhibition of glutamate transport in cultured astrocytes. Anesthesiology 90 (1999) 1446-1453
98. Sneyd J.R., Carr A., Byrom W.D., and Bilski A.J. A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur. J. Anaesthesiol. 15 (1998) 433-445
99. Song H.K., and Jeong D.C. The effect of propofol on cytotoxicity and apoptosis of lipopolysaccharide-treated mononuclear cells and lymphocytes. Anesth. Analg. 98 (2004) 1724-1728 table of contents
100. Stratford N., and Murphy P. Antioxidant activity of propofol in blood from anaesthetized patients. Eur. J. Anaesthesiol. 15 (1998) 158-160
101. Suzuki M., Li R.A., Miki T., Uemura H., Sakamoto N., Ohmoto-Sekine Y., Tamagawa M., Ogura T., Seino S., Marban E., and Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ. Res. 88 (2001) 570-577
102. Tanaka K., Ludwig L.M., Kersten J.R., Pagel P.S., and Warltier D.C. Mechanisms of cardioprotection by volatile anaesthetics. Anesthesiology 100 (2004) 707-721
103. Toller W.G., Gross E.R., Kersten J.R., Pagel P.S., Gross G.J., and Warltier D.C. Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology 92 (2000) 1731-1739
104. Tramer M.R., Reynolds D.J., Stoner N.S., Moore R.A., and McQuay H.J. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review. Eur. J. Cancer 34 (1998) 1836-1844
105. Tsai Y.C., Huang S.J., Lai Y.Y., Chang C.L., and Cheng J.T. Propofol does not reduce infarct volume in rats undergoing permanent middle cerebral artery occlusion. Acta Anaesthesiol. Sin. 32 (1994) 99-104
106. Tulving E. Episodic memory and common sense: how far apart?. Philos. Trans. R. Soc. Lond. 356 (2001) 1505-1515
107. Turkan H., Suer A.H., Beyan C., and Yalcin A. Propofol does not affect platelet aggregation. Eur. J. Anaesthesiol. 13 (1996) 408-409
108. Velly L.J., Guillet B.A., Masmejean F.M., Nieoullon A.L., Bruder N.J., Gouin F.M., and Pisano P.M. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters. Anesthesiology 99 (2003) 368-375
109. Veselis R.A., Reinsel R.A., Feshchenko V.A., and Dnistrian A.M. A neuroanatomical construct for the amnesic effects of propofol. Anesthesiology 97 (2002) 329-337
110. Veselis R.A., Reinsel R.A., Feshchenko V.A., and Johnson Jr. R. Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine. Anesthesiology 101 (2004) 831-841
111. Veselis R.A., Pryor K.O., Reinsel R.A., Mehta M., Pan H., and Johnson Jr. R. Low-dose propofol-induced amnesia is not due to a failure of encoding: left inferior prefrontal cortex is still active. Anesthesiology 109 (2008) 213-224
112. Volke V., Koks S., Vasar E., Bourin M., Bradwejn J., and Mannisto P.T. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport 6 (1995) 1413-1416
113. Wang J., Yang X., Camporesi C.V., Yang Z., Bosco G., Chen C., and Camporesi E.M. Propofol reduces infarct size and striatal dopamine accumulation following transient middle cerebral artery occlusion: a microdialysis study. Eur. J. Pharmacol. 452 (2002) 303-308
114. Wilder-Smith O.H., Kolletzki M., and Wilder-Smith C.H. Sedation with intravenous infusions of propofol or thiopentone. Effects on pain perception. Anaesthesia 50 (1995) 218-222
115. Wu K.K. Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators. Prostaglandins Leukot. Essent. Fat. Acids 72 (2005) 89-93
116. Xu T.L. Gamma-aminobutyric acid-induced responses in acutely dissociated neurons from the rat sacral dorsal commissural nucleus. J. Auton. Nerv. Syst. 75 (1999) 156-163
117. Yamada H., Kawano T., Tanaka K., Yasui S., Mawatari K., Takahashi A., Nakaya Y., and Oshita S. Effects of intracellular MgADP and acidification on the inhibition of cardiac sarcolemmal ATP-sensitive potassium channels by propofol. J. Anesth. 21 (2007) 472-479
118. Yamasaki T., Nakakimura K., Matsumoto M., Xiong L., Ishikawa T., and Sakabe T. Effects of graded suppression of the EEG with propofol on the neurological outcome following incomplete cerebral ischaemia in rats. Eur. J. Anaesthesiol. 16 (1999) 320-329
119. Zacny J.P., Coalson D.W., Young C.J., Klafta J.M., Lichtor J.L., Rupani G., Thapar P., and Apfelbaum J.L. Propofol at conscious sedation doses produces mild analgesia to cold pressor-induced pain in healthy volunteers. J. clin. anaesth. 8 (1996) 469-474
120. Zhan R.Z., Qi S., Wu C., Fujihara H., Taga K., and Shimoji K. Intravenous anaesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-d-aspartate receptor inhibition. Crit. Care Med. 29 (2001) 808-813
121. Zhang J., and Snyder S.H. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 213-233
122. Zhao X.J., and Cheung N.K. GD2 oligosaccharide: target for cytotoxic T lymphocytes. J. Exp. Med. 182 (1995) 67-74
123. Zhuo M.L., Huang Y., Liu D.P., and Liang C.C. KATP channel: relation with cell metabolism and role in the cardiovascular system. Int. J. Biochem. Cell Biol. 37 (2005) 751-764